FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology
Stock Information for FibroGen Inc
Loading
Please wait while we load your information from QuoteMedia.